Molecule interacting with CasL-2 enhances tumor progression and alters radiosensitivity in cervical cancer.

However, differences in OS between the groups did not reach statistical significance, potentially due to the small cohort size and limited duration of follow-up (Fig. 7 C).

also in 111,027 other papers